Notably, large-scale mapping of cancer dependencies showed that FGFR2-fusion+ ICC cells have significantly enriched dependency on SLC2A1 (encoding GLUT1, the high-affinity glucose transporter) relative to other cancer cell lines (Fig. 2l; see Methods), consistent with a particularly high demand for glucose at baseline. The gene discussed is SLC2A1; the disease is cancer.